Immunex Corporation Prepares for Next Wave of Growth with Leadership Appointment

Strategic Insights -

Immunex Corporation has announced the appointment of Peggy Phillips as the company's new executive vice president and chief operating officer. Phillips will oversee the integration of the company's sales and marketing functions into a new operational unit, effectively aligning responsibility for a new product from clinical study to patient reach. This strategic move is aimed at enhancing business efficiency, particularly as Immunex has established itself as a thriving pharmaceutical business.

Key Takeaways:

  • Peggy Phillips, 46, has been appointed as executive vice president and chief operating officer at Immunex Corporation.
  • Phillips will oversee the integration of sales and marketing functions with clinical development and manufacturing units.
  • This new structure aims to improve business efficiency by aligning responsibility for a new product's lifecycle.
  • Phillips has a strong background in management, having served in various positions at Immunex since 1986, including senior vice president for pharmaceutical development and general manager for ENBREL.
  • She was elected to the Immunex Board of Directors in 1996 and holds an M.S. in microbiology from the University of Idaho.
  • Immunex Corporation is a biopharmaceutical company dedicated to developing immune system science to protect human health.
  • The company's products offer promise to patients with cancer, inflammatory, and infectious diseases.
  • American Home Products Corporation (AHP) owns a majority interest in Immunex.

Statistics:

  • Immunex Corporation is a 15-year-old biopharmaceutical company.
  • AHP, the majority owner of Immunex, is one of the world's largest research-based pharmaceutical companies.
  • Immunex has a strong presence in the pharmaceutical industry, developing products for various diseases.
  • ENBREL, a breakthrough therapy for rheumatoid arthritis, was developed under Phillips' leadership.
  • Immunex's focus is on developing products that protect human health using immune system science.

Sources:

  • "Immunex Corporation Announces Appointment of Peggy Phillips as Chief Operating Officer" (PRNewswire, Oct. 11).
  • "Immunex Corporation Company Overview" (Immunex Corporation).